Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Alcohol Alcohol ; 55(1): 3-10, 2020 Feb 07.
Article in English | MEDLINE | ID: mdl-31845992

ABSTRACT

AIMS: We investigated the cardiac effects of ethanol withdrawal and the possible role of AT1 receptors in such response. METHODS: Male Wistar rats were treated with increasing doses of ethanol (3 to 9%, vol./vol.) for 21 days. The cardiac effects of ethanol withdrawal were investigated 48 h after abrupt discontinuation of ethanol. Some animals were orally treated with losartan (10 mg/kg/day), a selective AT1 receptor antagonist. RESULTS: Ethanol withdrawal did not affect serum levels of creatine kinase (CK)-MB. Losartan prevented ethanol withdrawal-induced increase in superoxide anion (O2•-) production in the left ventricle (LV). However, ethanol withdrawal did no alter the levels of thiobarbituric acid reactive substances (TBARS) or the expression of Nox1, Nox2 or Nox4 were found in the LV. Ethanol withdrawal reduced the concentration of hydrogen peroxide (H2O2) in the LV and this response was prevented by losartan. Ethanol withdrawal increased catalase activity in the LV and losartan attenuated this response. No changes on superoxide dismutase (SOD) activity or expression were detected in the LV during ethanol withdrawal. The expression of AT1, AT2 or angiotensin converting enzyme (ACE) was not affected by ethanol withdrawal. Similarly, no changes on the expression of ERK1/2, SAPK/JNK, COX-1 or COX-2 were found in the LV during ethanol withdrawal. CONCLUSIONS: Ethanol withdrawal altered the cardiac oxidative state through AT1-dependent mechanisms. Our findings showed a role for angiotensin II/AT1 receptors in the initial steps of the cardiac effects induced by ethanol withdrawal.


Subject(s)
Ethanol/adverse effects , Heart Ventricles/metabolism , Receptor, Angiotensin, Type 1/biosynthesis , Substance Withdrawal Syndrome/metabolism , Superoxides/metabolism , Animals , Catalase/metabolism , Creatine Kinase, MB Form/blood , Cyclooxygenase 1/biosynthesis , Cyclooxygenase 2/biosynthesis , Hydrogen Peroxide/metabolism , Losartan/pharmacology , Male , Membrane Proteins/biosynthesis , Mitogen-Activated Protein Kinase 1/biosynthesis , Mitogen-Activated Protein Kinase 3/biosynthesis , Mitogen-Activated Protein Kinase 8/biosynthesis , NADPH Oxidases/biosynthesis , Peptidyl-Dipeptidase A/biosynthesis , Rats , Receptor, Angiotensin, Type 2/biosynthesis , Substance Withdrawal Syndrome/blood , Substance Withdrawal Syndrome/prevention & control , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
2.
Pathol Res Pract ; 214(6): 907-913, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29559247

ABSTRACT

Ameloblastoma is a locally aggressive neoplasm with a poorly understood pathogenesis. Therefore, the aim of this study is to investigate whether COX-2 expression is associated with ameloblastoma microvascular density (MVD) and with tumor aggressiveness. Sixty-three cases of primary ameloblastomas arranged in tissue microarray were submitted to immunohistochemistry against cyclooxigenase-2 (COX-2) and CD34. Clinicopathological parameters regarding sex, age, tumour size, tumour duration, tumour location, treatment, recurrences, radiographic features, vestibular/lingual and basal cortical disruption and follow-up data were obtained from patients' medical records and correlated with the proteins expression. The results on BRAF-V600E expression were obtained from our previous study and correlated with COX-2 and CD34 expressions. Log-rank univariate analysis and multivariate Cox regression model were done to investigate the prognostic potential of the molecular markers. Twenty-eight cases (44.4%) exhibited cytoplasmic positivity for COX-2, predominantly in the columnar peripheral cells, with a mean MVD of 2.2 vessels/mm2. COX-2 was significantly associated with recurrences (p < 0.001) and BRAF-V600E expression (p < 0.001), whereas lower MVD was associated with the use of conservative therapy (p = 0.004). Using univariate and multivariate analyses, COX-2 was significantly associated with a lower 5-year disease-free survival (DFS) rate (p < 0.001 and p = 0.012, respectively), but not with a higher MVD (p = 0.68). In conclusion, COX-2 expression in ameloblastomas is not associated with MVD, but it is significantly associated with recurrences and with a lower DFS.


Subject(s)
Ameloblastoma/pathology , Biomarkers, Tumor/analysis , Cyclooxygenase 1/biosynthesis , Jaw Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Ameloblastoma/mortality , Child , Cyclooxygenase 1/analysis , Disease-Free Survival , Female , Humans , Jaw Neoplasms/mortality , Kaplan-Meier Estimate , Male , Middle Aged , Prognosis , Proportional Hazards Models , Retrospective Studies , Young Adult
3.
Fundam Clin Pharmacol ; 29(2): 150-63, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25619310

ABSTRACT

This study aimed to investigate the modulation of nitric oxide/reactive oxygen species in sodium nitroprusside relaxation in mice aorta. Sodium nitroprusside induced relaxation in endothelium-intact (e+) and endothelium-denuded (e-) aortas with greater potency in e+ than in e-. The nitric oxide synthase inhibitor did not alter the sodium nitroprusside relaxation in both e+ and e- aortas. However, the superoxide anion scavenger abolished the difference in sodium nitroprusside potency between e+ and e-. Sodium nitroprusside reduced dihydroethidium-derived fluorescent products in both groups; however, the difference between intact and denuded mice aorta remains. The glutathione levels and basal antioxidant activity of superoxide dismutase were reduced in e- aorta when compared with e+, and these values were not altered by sodium nitroprusside. Confirming these results, the levels of lipid peroxidation in e+ were significantly lower when compared to e-, and these values were not altered by sodium nitroprusside. The sodium nitroprusside potency in the presence of a nonselective COX inhibitor or the EP/DP prostaglandin receptor antagonist in endothelium denuded was similar to that in intact mice aorta. Based on these results, we performed the COX-1 and COX-2 mRNA level studies, and in denuded mice aorta, there was an upregulation in COX-1 mRNA levels. Taken together, our findings show that in the absence of endothelium, there is an enhancement of superoxide levels, leading to GSH consumption and higher levels of lipid peroxidation, showing an intense redox status. Furthermore, in denuded mice aorta, there was an upregulation of COX-1 mRNA expression, leading to vasoconstrictor prostanoids synthesis. The interaction of vasoconstrictor prostanoids with its receptors EP/DP negatively modulates the vascular relaxation induced by SNP in denuded mice aorta.


Subject(s)
Aorta, Thoracic/metabolism , Cyclooxygenase 1/biosynthesis , Membrane Proteins/biosynthesis , Nitroprusside/pharmacology , RNA, Messenger/biosynthesis , Reactive Oxygen Species/metabolism , Vasodilator Agents/pharmacology , Animals , Aorta, Thoracic/drug effects , Dose-Response Relationship, Drug , Male , Mice , Mice, Inbred C57BL , Organ Culture Techniques , Vasodilation/drug effects , Vasodilation/physiology
4.
Photochem Photobiol ; 87(5): 1159-63, 2011.
Article in English | MEDLINE | ID: mdl-21749398

ABSTRACT

We tested if modulation in mRNA expression of cyclooxygenase isoforms (COX-1 and COX-2) can be related to protective effects of phototherapy in skeletal muscle. Thirty male Wistar rats were divided into five groups receiving either one of four laser doses (0.1, 0.3, 1.0 and 3.0 J) or a no-treatment control group. Laser irradiation (904 nm, 15 mW average power) was performed immediately before the first contraction for treated groups. Electrical stimulation was used to induce six tetanic tibial anterior muscle contractions. Immediately after sixth contraction, blood samples were collected to evaluate creatine kinase activity and muscles were dissected and frozen in liquid nitrogen to evaluate mRNA expression of COX-1 and COX-2. The 1.0 and 3.0 J groups showed significant enhancement (P < 0.01) in total work performed in six tetanic contractions compared with control group. All laser groups, except the 3.0 J group, presented significantly lower post-exercise CK activity than control group. Additionally, 1.0 J group showed increased COX-1 and decreased COX-2 mRNA expression compared with control group and 0.1, 0.3 and 3.0 J laser groups (P < 0.01). We conclude that pre-exercise infrared laser irradiation with dose of 1.0 J enhances skeletal muscle performance and decreases post-exercise skeletal muscle damage and inflammation.


Subject(s)
Cyclooxygenase 1/biosynthesis , Cyclooxygenase 2/biosynthesis , Low-Level Light Therapy , Membrane Proteins/biosynthesis , Muscle, Skeletal/radiation effects , Physical Endurance/radiation effects , Animals , Creatine Kinase/blood , Dose-Response Relationship, Radiation , Electric Stimulation , Isometric Contraction/radiation effects , Lasers , Light , Male , Muscle Fatigue/physiology , Muscle Fatigue/radiation effects , Muscle, Skeletal/physiology , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction
5.
Stress ; 14(2): 216-26, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21291319

ABSTRACT

All forms of stress, including restraint stress (RS) and lipopolysaccharide (LPS) administration, activate the hypothalamic-pituitary-adrenal (HPA) axis. LPS binds to a recognition protein (CD14) and toll-like receptor 2/4 in different cells and tissues, including the adrenal gland, to induce the production of cytokines and cause upregulation of cyclooxygenase and nitric oxide synthase (NOS) enzymes. Acute ethanol exposure activates the HPA axis, but in some conditions prolonged administration can dampen this activation as well as decrease the inflammatory responses to LPS. Therefore, this study was designed to evaluate the adrenal response to a challenge dose of LPS (50 µg/kg) injected i.p., after submitting male rats to RS, twice a day (2 h each time) for 5 days and/or ethanol administration (3 g/kg) by gavage also for 5 days, twice daily. At the end of the experiment, plasma corticosterone concentrations and adrenal gland content of prostaglandin E (PGE) and NOS activity were measured as stress mediators. The results showed that repetitive ethanol administration attenuated the adrenal stress response to LPS challenge alone and after RS, by preventing the increase in plasma corticosterone concentrations and by decreasing the PGE content and NOS activity in the adrenal gland. Therefore, we conclude that moderate alcohol consumption could attenuate the effects of psychophysical stress and impair an inflammatory response.


Subject(s)
Adrenal Glands/drug effects , Adrenal Glands/physiology , Ethanol/pharmacology , Lipopolysaccharides/pharmacology , Animals , Corticosterone/blood , Cyclooxygenase 1/biosynthesis , Cyclooxygenase 2/biosynthesis , Inflammation/prevention & control , Lipopolysaccharide Receptors/metabolism , Lipopolysaccharides/antagonists & inhibitors , Male , Membrane Proteins/biosynthesis , Nitric Oxide Synthase/metabolism , Prostaglandins E/metabolism , Rats , Rats, Sprague-Dawley , Restraint, Physical , Stress, Psychological/drug therapy , Toll-Like Receptor 4/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL